Product Information
PHENOBARBITAL 32.4 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0757 per EA under NDC 16571067301. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
32.4 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571067301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/1/2020
Price Statistics
The NADAC for PHENOBARBITAL 32.4 MG TABLET has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 74.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0757 per EA |
|---|---|
| All-time high | $0.3215 (Mar 16, 2022) |
| All-time low | $0.0757 (Jun 17, 2026) |
| 52-week high | $0.1625 |
| 52-week low | $0.0757 |
| Median price | $0.1635 |
| Average price | $0.1850 |
| Largest weekly change | +62.6% (Jun 19, 2024) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 32.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 32.4 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0757 per EA (NDC 16571067301), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 32.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 32.4 MG TABLET has declined 74.7%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 32.4 MG TABLET?
Since Aug 4, 2021, the NADAC for PHENOBARBITAL 32.4 MG TABLET has ranged from a low of $0.0757 (Jun 17, 2026) to a high of $0.3215 (Mar 16, 2022), with a median of $0.1635 per EA.
Are there cheaper alternatives to PHENOBARBITAL 32.4 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 32.4 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 32.4 MG TABLET?
PHENOBARBITAL 32.4 MG TABLET (NDC 16571067301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification